In this discussion, OBN is joined by a panel of speakers all working to accelerate drug discovery. We’ll explore some of the key areas where improvements are being made - such as ensuring the right target, expanding the pool of high likelihood leads, or shortening development timelines - and discuss what roadblocks remain in development pipelines. Join us for what promises to be a fascinating discussion.